Biologics in Older Adults with Chronic Obstructive Pulmonary Disease: A Narrative Review
Journal of Clinical Medicine · 13.08.2026 · 15 (16) · 6277
DOI: 10.3390/jcm15166277 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 13.08.2026. Verfasst von Simone Scarlata und 9 weiteren Autor:innen. Beteiligte Einrichtung: Unit of Respiratory Pathophysiology, Department of Internal Medicine and Geriatrics, Campus Bio Medico University and Teaching Hospital, 00128 Rome, …. Die Arbeit nennt 102 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: COPD, Gerontologische Pflege
Abstract (Originalsprache)
Background
Chronic obstructive pulmonary disease (COPD) disproportionately affects older adults. While targeted biologic therapies have shown efficacy in type 2 eosinophilic endotypes, elderly patients remain underrepresented in pivotal clinical trials. This narrative review examines the pathophysiological rationale, efficacy data, and unique geriatric challenges of biologic therapies in older adults.
Methods
A literature search was conducted in PubMed and Scopus for phase II and III randomized controlled trials (RCTs) and observational studies evaluating biologic agents (anti-IL-5, anti-IL-4/IL-13, and anti-alarmins) in COPD, focusing on populations aged ≥ 65 years, comorbidities, and frailty.
Discussion
Phase III data for dupilumab and mepolizumab indicate significant reductions in annualized exacerbations in patients with blood eosinophils ≥ 300 cells/μL. However, the mean age in the landmark trials (65 years) is a decade lower than the real-world average. Age-related immune remodeling—specifically immunosenescence and inflammaging—coexists with disease-specific pathways, potentially altering therapeutic responses. Furthermore, clinical trials systematically exclude older individuals with severe multimorbidity, physical frailty, cognitive impairment, and malnutrition.
Conclusions
Biologics provide a precise, mechanism-based approach, yet evidence in the oldest-old remains limited. Future management should utilize the treatable traits framework, shifting selection criteria from chronological age to biological age metrics, including frailty status and functional reserve.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Unit of Respiratory Pathophysiology, Department of Internal Medicine and Geriatrics, Campus Bio Medico University and Teaching Hospital, 00128 Rome, Italy.
- Institute of Respiratory Disease, Department of Traslational Biomedicine and Applied Neuroscience, University of Bari "Aldo Moro", 70124 Bari, Italy.
- Division of Respiratory Medicine, PROMISE Department, "Paolo Giaccone" University Hospital, 90127 Palermo, Italy.
- Department of Pulmonology and Cardiorespiratory Rehabilitation, Sant'Antonio Hospital, 22063 Cantu, Italy.
ORCID-Profile: Simone Scarlata, Alessio Marinelli, Panaiotis Finamore, Vitaliano Nicola Quaranta, Giulia Amoroso, Alessandra Tomasello, Claudio Sorino, Giovanna Elisiana Carpagnano, Nicola Scichilone, Silvano Dragonieri
Zitieren
APA
Scarlata, S., Marinelli, A., Finamore, P., Quaranta, V. N., Amoroso, G., Tomasello, A., Sorino, C., Carpagnano, G. E., Scichilone, N., & Dragonieri, S. (2026). Biologics in Older Adults with Chronic Obstructive Pulmonary Disease: A Narrative Review. Journal of Clinical Medicine, 15(16), 6277. https://doi.org/10.3390/jcm15166277
Vancouver
Scarlata S, Marinelli A, Finamore P, Quaranta VN, Amoroso G, Tomasello A, et al. Biologics in Older Adults with Chronic Obstructive Pulmonary Disease: A Narrative Review. Journal of Clinical Medicine. 2026;15(16):6277. doi:10.3390/jcm15166277
BibTeX
@article{Scarlata2026,
author = {Scarlata, Simone and Marinelli, Alessio and Finamore, Panaiotis and Quaranta, Vitaliano Nicola and Amoroso, Giulia and Tomasello, Alessandra and Sorino, Claudio and Carpagnano, Giovanna Elisiana and Scichilone, Nicola and Dragonieri, Silvano},
title = {Biologics in Older Adults with Chronic Obstructive Pulmonary Disease: A Narrative Review},
journal = {Journal of Clinical Medicine},
year = {2026},
volume = {15},
number = {16},
pages = {6277},
doi = {10.3390/jcm15166277}
}
EUVIMED